RYR2 mutations may cause catecholaminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia (ARVD) [65], [66]. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.